Removing Transfusion Dependence as a Barrier to Hospice Enrollment
- Status
- COMPLETED
- Phase
- NA
Clinical Trials Related to Acute Myeloid Leukemia
Related studies linked through entity extraction aliases.
A Study to Evaluate the Safety and Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of Max-40279-01 in Combination With Azacitidine (AZA) in Patients With Myelodysplastic Syndrome (MDS) or Relapsed/Refractory Acute Myeloid Leukemia (R/R AML)
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Extramedullary Acute Myeloid Leukemia (eAML): Retrospective Single Center Cohort Study, Clinicopathological, Molecular Analysis and Survival Outcomes
- Status
- COMPLETED
- Phase
- N/A
A Study to Evaluate the Safety and Tolerance of SYHX1903 in Patients With Relapsed/Refractory Hematologic Malignancies
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Bcl-2 Inhibitors Combined With Azacytidine and Chemotherapy in Elderly Patients With Previously Untreated AML
- Status
- UNKNOWN
- Phase
- NA
Clinical Research for Azacitidine Combined With Low-dose Dasatinib in Maintenance Therapy of Acute Myeloid Leukemia
- Status
- UNKNOWN
- Phase
- NA
XmAb18968 (CD3-CD38) in Relapsed or Refractory Acute Leukemia and T Cell Lymphoblastic Leukemia
- Status
- TERMINATED
- Phase
- PHASE1
Anti-Leukemia Immune Responses After Irradiation of Extramedullary Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- EARLY_PHASE1
Two Step Haplo With Radiation Conditioning
- Status
- RECRUITING
- Phase
- PHASE2
New Double Epigenetic Regimen in the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study to Evaluate Lanraplenib (LANRA) in Combination With Gilteritinib in Participants With FLT3-mutated Relapsed or Refractory Acute Myeloid Leukemia (AML)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Study of E7820 in People With Bone Marrow (Myeloid) Cancers
- Status
- COMPLETED
- Phase
- PHASE2
Anti-FLT3 CAR T-cell Therapy in FLT3 Positive Relapsed/Refractory Acute Myeloid Leukemia
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
TAA05 Cell Injection in the Treatment of Recurrent / Refractory Acute Myeloid Leukemia
- Status
- RECRUITING
- Phase
- NA
Application of Nanopore Sequencing in Newly Diagnosed Acute Myeloid Leukemia Patients With Bloodstream Infection
- Status
- UNKNOWN
- Phase
- N/A
Gamma Delta T-cell Infusion for AML at High Risk of Relapse After Allo HCT
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Backtracking Leukemia-Typical Somatic Mutations in Cord Blood
- Status
- RECRUITING
- Phase
- N/A
Decitabine Alone or in Combination With Venetoclax, Gilteritinib, Enasidenib, or Ivosidenib as Maintenance Therapy for the Treatment of Acute Myeloid Leukemia in Remission
- Status
- RECRUITING
- Phase
- PHASE1
ASTX727, Venetoclax, and Gilteritinib for the Treatment of Newly Diagnosed, Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Study of GDX012 in Patients With MRD Positive AML
- Status
- TERMINATED
- Phase
- PHASE1